Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

CXCR1/CXCR2 receptor antagonists a focus of research at Warner-Lambert

Sep. 17, 1999

Warner-Lambert discloses new IL-8 (CXCR1/CXCR2) receptor antagonists

Sep. 16, 1999

Abgenix reports positive preclinical results for ABX-IL-8

Sep. 15, 1999

Hair growth promoters developed at Shiseido

Sep. 13, 1999

Access initiates clinical trial of OraDisc for amlexanox delivery

Sep. 10, 1999

Fujisawa seeks approval for tacrolimus ointment in the U.S.

Sep. 10, 1999

Vitrix soon to enter expanded clinical development

Sep. 10, 1999

Licensing opportunity from NIH: thymosin beta4 as a wound-healing agent

Sep. 7, 1999

Genzyme Tissue Repair's TGF-beta2 sponge evaluated in phase II diabetic foot ulcers

Sep. 3, 1999

ACS news: new compounds from Merck & Co. potently and selectively inhibit 5alpha-reductase type 1

Sep. 1, 1999

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...